Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis
Takayasu arteritis (TA) is a chronic inflammatory disease of unknown origin that involves large and mediumsized arteries, primarily the aorta and its major branches. TA is a therapeutic challenge because corticosteroids and conventional immunosuppressive agents are not always effective or safe. Inte...
Saved in:
Main Authors: | A. Lo Gullo (Author), G. Mandraffino (Author), C.O. Aragona (Author), A. Molica Colella (Author), A. Saitta (Author), E. Imbalzano (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tocilizumab for faster and safer remission of Takayasu's arteritis
by: Hua Liao, et al.
Published: (2022) -
Takayasu arteritis of atypical presentation. Tocilizumab as an alternative therapeutic option
by: Zaira Cubiles Arillo, et al.
Published: (2019) -
Takayasu Arteritis
by: Ricardo A. G. Russo, et al.
Published: (2018) -
Arteritis de Takayasu de presentación atípica. Tocilizumab como alternativa terapéutica
by: Zaira Cubiles Arillo, et al.
Published: (2019) -
Horner syndrome as a manifestation of an exacerbation of Takayasu's arteritis
by: Co Dominic, et al.
Published: (2012)